Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2024 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Gains from Investment Securities came in at $8271.0 in Q1 2026, up 102.12% YoY from $4092.1 in Q1 2025, and up 103.71% on a QoQ basis from -$222740.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 3 years of Gains from Investment Securities data on file, last reported at $8271.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 102.12% year-over-year to $8271.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$219343.0 (changed N/A YoY) and the FY2025 annual result came in at -$784670.0, down 339.89% from the prior year.
- Gains from Investment Securities advanced to $8271.0 in Q1 2026, from -$222740.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $314751.0 in Q3 2025 to a low of -$390351.0 in Q1 2025.
- A 3-year average of -$166523.2 and a median of -$271182.5 in 2025 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2025 — Gains from Investment Securities surged 42.81% — and 2026, when it soared 102.12%.
- Tracing NMTC's Gains from Investment Securities over 3 years: stood at -$389445.0 in 2024, then soared by 42.81% to -$222740.0 in 2025, then surged by 103.71% to $8271.0 in 2026.
- The last three Gains from Investment Securities figures came in at $8271.0 (Q1 2026), -$222740.0 (Q4 2025), and $314751.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 19.64 Mn | 17.59 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -405,702.00 |
| Jun 30, 2026 | -405,702.00 |
| Mar 31, 2026 | 8,271.00 |
| Mar 31, 2026 | 8,271.00 |
| Dec 31, 2025 | -222,740.00 |
| Dec 31, 2025 | -222,740.00 |
| Sep 30, 2025 | 314,751.00 |
| Sep 30, 2025 | 314,751.00 |
| Jun 30, 2025 | -319,625.00 |
| Jun 30, 2025 | -319,625.00 |
| Mar 31, 2025 | -390,351.00 |
| Mar 31, 2025 | -390,351.00 |
| Dec 31, 2024 | -389,445.00 |
| Dec 31, 2024 | -389,445.00 |